Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [11] The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial
    Joerg C Schefold
    Stephan von Haehling
    Rene Pschowski
    Thorsten Onno Bender
    Cathrin Berkmann
    Sophie Briegel
    Dietrich Hasper
    Achim Jörres
    Critical Care, 18
  • [12] Management of acute renal replacement therapy in critically ill cirrhotic patients
    Del Risco-Zevallos, Jimena
    Molina Andujar, Alicia
    Pineiro, Gaston
    Reverter, Enric
    David Toapanta, Nestor
    Sanz, Miquel
    Blasco, Miquel
    Fernandez, Javier
    Poch, Esteban
    CLINICAL KIDNEY JOURNAL, 2022, 15 (06) : 1060 - 1070
  • [13] Influence of renal replacement therapy on outcome of patients with acute renal failure
    Kresse, S
    Schlee, H
    Deuber, HJ
    Koall, W
    Osten, B
    KIDNEY INTERNATIONAL, 1999, 56 : S75 - S78
  • [14] Acute renal failure in critically ill HIV-infected patients
    Lopes J.A.
    Fernandes J.
    Jorge S.
    Neves J.
    Antunes F.
    Prata M.M.
    Critical Care, 11 (1):
  • [15] AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
    Gupta, Shruti
    Coca, Steven G.
    Chan, Lili
    Melamed, Michal L.
    Brenner, Samantha K.
    Hayek, Salim S.
    Sutherland, Anne
    Puri, Sonika
    Srivastava, Anand
    Leonberg-Yoo, Amanda
    Shehata, Alexandre M.
    Flythe, Jennifer E.
    Rashidi, Arash
    Schenck, Edward J.
    Goyal, Nitender
    Hedayati, S. Susan
    Dy, Rajany
    Bansal, Anip
    Athavale, Ambarish
    Nguyen, H. Bryant
    Vijayan, Anitha
    Charytan, David M.
    Schulze, Carl E.
    Joo, Min J.
    Friedman, Allon N.
    Zhang, Jingjing
    Sosa, Marie Anne
    Judd, Eric
    Velez, Juan Carlos Q.
    Mallappallil, Mary
    Redfern, Roberta E.
    Bansal, Amar D.
    Neyra, Javier A.
    Liu, Kathleen D.
    Renaghan, Amanda D.
    Christov, Marta
    Molnar, Miklos Z.
    Sharma, Shreyak
    Kamal, Omer
    Boateng, Jeffery Owusu
    Short, Samuel A. P.
    Admon, Andrew J.
    Sise, Meghan E.
    Wang, Wei
    Parikh, Chirag R.
    Leaf, David E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 161 - 176
  • [16] Acute renal replacement therapies in critically ill patients
    Fuentes, A. Veronica
    REVISTA MEDICA CLINICA LAS CONDES, 2024, 35 (01): : 14 - 21
  • [17] Continuous renal replacement therapy in critically ill patients
    Ronco, C
    Bellomo, R
    Ricci, Z
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 67 - 72
  • [18] Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury
    Ron Wald
    William Beaubien-Souligny
    Rahul Chanchlani
    Edward G. Clark
    Javier A. Neyra
    Marlies Ostermann
    Samuel A. Silver
    Suvi Vaara
    Alexander Zarbock
    Sean M. Bagshaw
    Intensive Care Medicine, 2022, 48 : 1368 - 1381
  • [19] Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury
    Wald, Ron
    Beaubien-Souligny, William
    Chanchlani, Rahul
    Clark, Edward G.
    Neyra, Javier A.
    Ostermann, Marlies
    Silver, Samuel A.
    Vaara, Suvi
    Zarbock, Alexander
    Bagshaw, Sean M.
    INTENSIVE CARE MEDICINE, 2022, 48 (10) : 1368 - 1381
  • [20] Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury
    Bagshaw, Sean M.
    Uchino, Shigehiko
    Bellomo, Rinaldo
    Morimatsu, Hiroshi
    Morgera, Stanislao
    Schetz, Miet
    Tan, Ian
    Bouman, Catherine
    Macedo, Ettiene
    Gibney, Noel
    Tolwani, Ashita
    Oudemans-van Straaten, Heleen M.
    Ronco, Claudio
    Kellum, John A.
    JOURNAL OF CRITICAL CARE, 2009, 24 (01) : 129 - 140